Reply from authors: the use of blood coagulation products requires a thorough re-evaluation.

Vibede, E; Hvas, C L; Tønnesen, E; Hvas, A-M

Vibede, E; Hvas, C L; Tønnesen, E; Hvas, A-M.

Afiliação

Vibede E; Department of Clinical Biochemistry, Centre for Haemophilia and Thrombosis, Aarhus University Hospital, Aarhus N, Denmark.
Hvas CL; Department of Anaesthesiology and Intensive Care Medicine, Aarhus University Hospital, Aarhus N, Denmark.
Tønnesen E; Department of Anaesthesiology and Intensive Care Medicine, Aarhus University Hospital, Aarhus N, Denmark.
Hvas AM; Department of Clinical Biochemistry, Centre for Haemophilia and Thrombosis, Aarhus University Hospital, Aarhus N, Denmark.

Acta Anaesthesiol Scand ; 61(7): 855, 2017 08.

Article em En | MEDLINE | ID: mdl-28639352

Assuntos

Coagulação Sanguínea; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Coagulação Sanguínea Limite: Humans Idioma: En Revista: Acta Anaesthesiol Scand Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google